SC Filed 2019-03-25 Event — SEC 0001193125-19-085311 →

New Leaf Ventures III, L.P. → PDS Biotechnology Corp PDSB

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100

Passive Schedule 13G filer baseline
Short interest building (+22.3% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

13 transactions

13 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

3,387,210 shares short · +22.3% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-18	Ramsdell Deborah	director	Award	22,700	$1.13	$26K
2026-10-18	Wendel Bruce	director	Award	22,700	$1.13	$26K
2026-01-12	BEDU-ADDO FRANK	director, officer	Award	548,782	$0.98	$538K
2026-01-12	CONN GREGORY	officer	Award	150,000	$0.98	$147K
2026-01-12	Shepard Kirk V.	officer	Award	300,000	$0.98	$294K
2026-01-12	Boesgaard Lars	officer	Award	300,000	$0.98	$294K
2026-01-12	Brown Spencer D.	officer	Award	300,000	$0.98	$294K
2026-01-12	Toutain Stephan	officer	Award	300,000	$0.98	$294K
2026-01-12	Freitag Gregory Gene	director	Award	54,876	$0.98	$54K
2026-01-12	Iliev Ilian	director	Award	54,876	$0.98	$54K
2026-01-12	Ali-Jackson Kamil	director	Award	54,876	$0.98	$54K
2026-01-12	BRAWLEY OTIS W	director	Award	54,876	$0.98	$54K
2026-01-12	Glover Stephen C.	director	Award	54,876	$0.98	$54K

Other 13D/G Filings on PDS Biotechnology Corp

Filed	Form	Filer	Stake	Shares
2026-09-21	SCHEDULE 13D	Nant Capital, LLC	19.90%	20,336,335	view →
2021-06-21	SC	NETSCIENTIFIC PLC	—	—	view →

Other Filings by New Leaf Ventures III, L.P.

Filed	Form	Issuer	Stake	Shares
2022-02-11	SC	Aptinyx Inc.	—	—	view →
2019-11-15	SC	Deciphera Pharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →